Plutux
$1.33
-1.85%
N/A-$0.03
Healthcare
Biotechnology
NASDAQ
Active Trading

Ocugen, Inc. is a biopharmaceutical company in the clinical development phase, primarily dedicated to pioneering gene therapies aimed at treating various ophthalmic ...

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

© Plutux Technology Limited 2026
Ocugen, Inc. (OCGN) insider transactions